Virtus ETF Advisers LLC cut its stake in shares of Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) by 11.5% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 17,981 shares of the company’s stock after selling 2,328 shares during the quarter. Virtus ETF […]
Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) insider Peter Heerma sold 1,559 shares of the firm’s stock in a transaction that occurred on Tuesday, January 23rd. The stock was sold at an average price of $9.07, for a total transaction of $14,140.13. Following the sale, the insider now directly owns 78,698 shares of the […]
Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) has been assigned an average rating of “Moderate Buy” from the fifteen brokerages that are currently covering the firm, Marketbeat Ratings reports. Five research analysts have rated the stock with a hold rating and ten have issued a buy rating on the company. The average 12 month […]
Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) has earned an average recommendation of “Moderate Buy” from the fifteen ratings firms that are currently covering the company, MarketBeat.com reports. Five analysts have rated the stock with a hold recommendation and ten have given a buy recommendation to the company. The average twelve-month price target among […]
Shares of Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) shot up 4.3% on Wednesday . The company traded as high as $9.34 and last traded at $9.28. 491,452 shares traded hands during mid-day trading, a decline of 67% from the average session volume of 1,474,065 shares. The stock had previously closed at $8.90. Analysts […]